Sangamo Therapeutics Inc Equity-NMS: SGMO

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$0.5413
Open :	$0.53
Today's high :	$0.54
Today's low :	$0.51
52W low :	$0.304
52W high :	$3.179
1Y :	39.43%
5Y :	-94.24%
EPS(TTM): :	-0.36
Shares O/S :	245.4 M
Market cap :	132.52 M

What is the share price of Sangamo Therapeutics Inc today?

Sangamo Therapeutics Inc (SGMO) share price as of June 30, 2025, is $0.5413. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sangamo Therapeutics Inc?

Yes, Indian Investors can invest in the Sangamo Therapeutics Inc (SGMO) Share by opening an international trading account with Angel One.

How can I purchase Sangamo Therapeutics Inc shares in India?

Purchasing Sangamo Therapeutics Inc (SGMO) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sangamo Therapeutics Inc (SGMO) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sangamo Therapeutics Inc?

Yes, you can purchase fractional shares of Sangamo Therapeutics Inc (SGMO) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sangamo Therapeutics Inc?

The market capitalization of Sangamo Therapeutics Inc on June 30, 2025, is $0.

In which sector Sangamo Therapeutics Inc belongs?

Sangamo Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Sangamo Therapeutics Inc stocks?

In order to invest in Sangamo Therapeutics Inc (SGMO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sangamo Therapeutics, Inc. is a genomic medicine company. The Company’s zinc finger (ZF) epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid engineering platform has demonstrated the ability to expand delivery beyond available intrathecal delivery capsids, including in the central nervous system (CNS), in preclinical studies. Zinc finger technologies are derived from naturally occurring human proteins. They are composed of a DNA-binding domain, which binds with precision to any sequence of DNA, and various functional domains (such as nucleases and transcription factors) based on therapeutic needs. Its pipeline includes Chronic Neuropathic Pain - ST-503 and Isaralgagene civaparvovec (ST-920). ST-503 is an investigational epigenetic regulator for the treatment of intractable pain due to iSFN, a type of chronic neuropathic pain. ST-920 is a wholly owned gene therapy product candidate for the treatment of Fabry disease.